303 related articles for article (PubMed ID: 26357957)
21. The evolution of seasonal influenza viruses.
Petrova VN; Russell CA
Nat Rev Microbiol; 2018 Jan; 16(1):47-60. PubMed ID: 29081496
[TBL] [Abstract][Full Text] [Related]
22. Influenza viruses: breaking all the rules.
Taubenberger JK; Morens DM
mBio; 2013 Jul; 4(4):. PubMed ID: 23860766
[TBL] [Abstract][Full Text] [Related]
23. Influenza vaccine--outmaneuvering antigenic shift and drift.
Treanor J
N Engl J Med; 2004 Jan; 350(3):218-20. PubMed ID: 14724300
[No Abstract] [Full Text] [Related]
24. Use of animal models to understand the pandemic potential of highly pathogenic avian influenza viruses.
Belser JA; Szretter KJ; Katz JM; Tumpey TM
Adv Virus Res; 2009; 73():55-97. PubMed ID: 19695381
[TBL] [Abstract][Full Text] [Related]
25. The DBA.2 mouse is susceptible to disease following infection with a broad, but limited, range of influenza A and B viruses.
Pica N; Iyer A; Ramos I; Bouvier NM; Fernandez-Sesma A; García-Sastre A; Lowen AC; Palese P; Steel J
J Virol; 2011 Dec; 85(23):12825-9. PubMed ID: 21917963
[TBL] [Abstract][Full Text] [Related]
26. Circulation of classical swine influenza virus in Europe between the wars?
Lange J; Groth M; Kanrai P; Pleschka S; Scholtissek C; Dürrwald R; Platzer M; Sauerbrei A; Zell R
Arch Virol; 2014 Jun; 159(6):1467-73. PubMed ID: 24337721
[TBL] [Abstract][Full Text] [Related]
27. Fluarix quadrivalent vaccine for influenza.
Graaf Hd; Faust SN
Expert Rev Vaccines; 2015; 14(8):1055-63. PubMed ID: 26098443
[TBL] [Abstract][Full Text] [Related]
28. In contrast to conventional inactivated influenza vaccines, 4xM2e.HSP70c fusion protein fully protected mice against lethal dose of H1, H3 and H9 influenza A isolates circulating in Iran.
Ebrahimi SM; Dabaghian M; Tebianian M; Jazi MH
Virology; 2012 Aug; 430(1):63-72. PubMed ID: 22595444
[TBL] [Abstract][Full Text] [Related]
29. Knowns and unknowns of influenza B viruses.
Koutsakos M; Nguyen TH; Barclay WS; Kedzierska K
Future Microbiol; 2016; 11(1):119-35. PubMed ID: 26684590
[TBL] [Abstract][Full Text] [Related]
30. [Interspecies transmission, adaptation to humans and pathogenicity of animal influenza viruses].
Munier S; Moisy D; Marc D; Naffakh N
Pathol Biol (Paris); 2010 Apr; 58(2):e59-68. PubMed ID: 20303675
[TBL] [Abstract][Full Text] [Related]
31. Generation and evaluation of an H9N1 influenza vaccine derived by reverse genetics that allows utilization of a DIVA strategy for control of H9N2 avian influenza.
Wu R; Chen Q; Zheng L; Chen J; Sui Z; Guan Y; Chen Z
Arch Virol; 2009; 154(8):1203-10. PubMed ID: 19543688
[TBL] [Abstract][Full Text] [Related]
32. A review of the value of quadrivalent influenza vaccines and their potential contribution to influenza control.
Ray R; Dos Santos G; Buck PO; Claeys C; Matias G; Innis BL; Bekkat-Berkani R
Hum Vaccin Immunother; 2017 Jul; 13(7):1640-1652. PubMed ID: 28532276
[TBL] [Abstract][Full Text] [Related]
33. Evolutionary pattern of reemerging influenza B/Victoria lineage viruses in São Paulo, Brazil, 1996-2012: Implications for vaccine composition strategy.
Paiva TM; Benega MA; Silva DB; Santos KC; Cruz AS; Hortenci MF; Barbieri MT; Monteiro MM; Barbosa HA; Carvalhanas TR
J Med Virol; 2013 Nov; 85(11):1983-9. PubMed ID: 23926069
[TBL] [Abstract][Full Text] [Related]
34. [Influenza in the 1996/'97 season; vaccine composition for the 1997/'98 season].
Rimmelzwaan GF; de Jong JC; Bartelds AI; Claas EC; van Wijngaarden JK; Osterhaus AD
Ned Tijdschr Geneeskd; 1997 Sep; 141(36):1743-7. PubMed ID: 9545718
[TBL] [Abstract][Full Text] [Related]
35. [Influenza season 2007/'08 in the Netherlands: antigenic variation, oseltamivir resistance and vaccine composition for the 2008/'09 season].
Rimmelzwaan GF; de Jong JC; Donker GA; Meijer A; Fouchier RA; Osterhaus AD
Ned Tijdschr Geneeskd; 2008 Sep; 152(39):2138-44. PubMed ID: 18856032
[TBL] [Abstract][Full Text] [Related]
36. Innate and adaptive immunity toward influenza B viruses.
Hensen L; Kedzierska K; Koutsakos M
Future Microbiol; 2020 Jul; 15():1045-1058. PubMed ID: 32811172
[TBL] [Abstract][Full Text] [Related]
37. [The 2003/2004 influenza season in the Netherlands with a limited epidemic of the virus variant A/Fujian, and the vaccine composition for the 2004/2005 season].
Rimmelzwaan GF; de Jong JC; Bartelds AI; Wilbrink B; Fouchier RA; Osterhaus AD
Ned Tijdschr Geneeskd; 2004 Oct; 148(40):1984-8. PubMed ID: 15524136
[TBL] [Abstract][Full Text] [Related]
38. [Encephalopathy and encephalitis--influenza-associated neurological sequels].
Rybicka K; Brydak LB
Pol Merkur Lekarski; 2005 Oct; 19(112):501-5. PubMed ID: 16379311
[TBL] [Abstract][Full Text] [Related]
39. Large-scale sequencing of human influenza reveals the dynamic nature of viral genome evolution.
Ghedin E; Sengamalay NA; Shumway M; Zaborsky J; Feldblyum T; Subbu V; Spiro DJ; Sitz J; Koo H; Bolotov P; Dernovoy D; Tatusova T; Bao Y; St George K; Taylor J; Lipman DJ; Fraser CM; Taubenberger JK; Salzberg SL
Nature; 2005 Oct; 437(7062):1162-6. PubMed ID: 16208317
[TBL] [Abstract][Full Text] [Related]
40. Ecological and immunological determinants of influenza evolution.
Ferguson NM; Galvani AP; Bush RM
Nature; 2003 Mar; 422(6930):428-33. PubMed ID: 12660783
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
